News · Nephrology
282 stories
Oct 20, 26‘A two-way conversation with the tumor’: Researchers use ‘avatar’ to predict immunotherapy responses
Oct 16, 26City goes public with $200M IPO, while Frazier Life Sciences takes biotech-focused SPAC to Nasdaq
Oct 15, 26Estuary flows out of stealth with $103M to propel kidney disease gene therapies into clinic